企業プロフィール
Evelo Biosciences 株価・ニュース・カタリスト
- ティッカー:
- EVLO
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (-99.00%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
Current closing-price context is not available for EVLO.
企業概要
事業概要
Evelo Biosciences was a biotechnology company that explored oral biologics and immune system modulation before becoming a legacy ticker. Its story was centered on the challenge of turning a novel biology concept into durable human data.
所在地とセクター分類
Evelo was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotechnology and immunology.
ビジネスモデルの特徴
The company depended on translational validation, clinical data, and access to capital. Investors historically watched whether the platform could show enough differentiation to survive in a crowded biotech market.
バイオ業界での位置付け
Evelo is best viewed as a historical platform-biotech name. Its valuation was always tied to science proof and capital runway more than commercial scale.
今後のカタリスト
- Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is focused on what value remains.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。